Hsbc Holdings PLC Raises Stock Holdings in Globe Life Inc. $GL

Hsbc Holdings PLC grew its position in Globe Life Inc. (NYSE:GL) by 19.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 129,997 shares of the company’s stock after acquiring an additional 20,743 shares during the quarter. Hsbc Holdings PLC’s holdings in Globe Life were worth $18,225,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of GL. MidFirst Bank purchased a new position in shares of Globe Life during the fourth quarter worth approximately $529,000. Compound Planning Inc. raised its position in Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after purchasing an additional 82 shares during the last quarter. Invesco Ltd. raised its position in Globe Life by 2.7% in the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after purchasing an additional 102,445 shares during the last quarter. Strive Financial Group LLC acquired a new stake in Globe Life during the 4th quarter worth $1,974,000. Finally, Vident Advisory LLC boosted its stake in Globe Life by 57.7% during the 4th quarter. Vident Advisory LLC now owns 19,650 shares of the company’s stock worth $2,748,000 after purchasing an additional 7,189 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Stock Performance

NYSE:GL opened at $176.80 on Friday. The firm’s fifty day moving average price is $157.72 and its 200 day moving average price is $147.09. Globe Life Inc. has a 1-year low of $116.73 and a 1-year high of $181.15. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The firm has a market cap of $13.73 billion, a price-to-earnings ratio of 12.23 and a beta of 0.49.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The firm had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, sell-side analysts expect that Globe Life Inc. will post 15.64 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is currently 9.13%.

Insiders Place Their Bets

In related news, CFO Thomas Peter Kalmbach sold 7,936 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.59, for a total transaction of $1,242,698.24. Following the transaction, the chief financial officer owned 50,496 shares of the company’s stock, valued at $7,907,168.64. This represents a 13.58% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael Clay Majors sold 34,000 shares of the stock in a transaction on Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the completion of the transaction, the executive vice president owned 53,518 shares of the company’s stock, valued at $8,231,603.58. The trade was a 38.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 115,929 shares of company stock valued at $18,049,250 in the last three months. 2.11% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

GL has been the topic of a number of recent research reports. TD Cowen lifted their price objective on shares of Globe Life from $199.00 to $215.00 and gave the company a “buy” rating in a research note on Tuesday. Keefe, Bruyette & Woods reiterated a “moderate buy” rating and set a $168.00 target price on shares of Globe Life in a research note on Thursday, March 26th. Wells Fargo & Company raised their price target on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a report on Friday, April 10th. Morgan Stanley boosted their price target on Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, May 21st. Finally, Piper Sandler upped their price objective on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $175.89.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.